Cagrilintide + Semaglutide
Pilih Format
Pilih Konsentrasi
SKU: AETHER-CGRS-10MGTOTAL-10VIALS
Key Benefits
- Combined formulation, titrate according to protocol
Common Research Uses
- Cagrilintide + Semaglutide | Research Peptide | Aether Bio
Dosage Guidelines
Disclaimer: The dosages listed are not recommendations. This is a general guideline based on information we have gathered from various sources. Please consult with qualified researchers and professionals before use.
Cagrilintide + Semaglutide, GLP-1 agonist, weight loss peptide, synergistic weight loss beyond either alone, dual mechanism of action, enhanced satiety and appetite control, research peptide, Aether Bio
Product Details
CagriSema is a fixed combination of Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist). The combination engages amylin and GLP-1 axes simultaneously for orthogonal satiety and glucose-homeostasis signaling.
Mechanism of Action. Cagrilintide engages the amylin receptor (gastric emptying, area-postrema satiety) while Semaglutide engages the GLP-1 receptor (insulin secretion, hypothalamic satiety). The two pathways are complementary.
Applications. Multi-axis incretin/amylin research, comparative satiety-pathway studies, body-weight and metabolic modeling.
Customer Reviews
No reviews yet
Be the first to share your experience
Questions about this product?
Our team can help with specs, bulk orders, or custom concentrations.